Semisynthetic neoclerodanes as kappa opioid receptor probes

被引:23
|
作者
Lovell, Kimberly M. [1 ]
Vasiljevik, Tamara [1 ]
Araya, Juan J. [1 ]
Lozama, Anthony [2 ]
Prevatt-Smith, Katherine M. [1 ]
Day, Victor W. [1 ]
Dersch, Christina M. [3 ]
Rothman, Richard B. [3 ]
Butelman, Eduardo R. [4 ]
Kreek, Mary Jeanne [4 ]
Prisinzano, Thomas E. [1 ]
机构
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA
[2] Univ Iowa, Div Med & Nat Prod Chem, Iowa City, IA 52242 USA
[3] NIDA, Clin Psychopharmacol Sect, IRP, DHHS, Baltimore, MD 21224 USA
[4] Rockefeller Univ, Lab Biol Addict Dis, New York, NY USA
基金
美国国家科学基金会;
关键词
Natural product; Salvinorin A; Salvia divinorum; Kappa opioid receptor; Hallucinogen; Furan; SALVINORIN-A; SALVIA-DIVINORUM; NATURAL-PRODUCTS; LIGANDS; AGONIST; TRANSFORMATIONS; IDENTIFICATION; HALLUCINOGEN; ANTAGONISTS; DITERPENES;
D O I
10.1016/j.bmc.2012.02.040
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Modification of the furan ring of salvinorin A (1), the main active component of Salvia divinorum, has resulted in novel neoclerodane diterpenes with opioid receptor affinity and activity. Conversion of the furan ring to an aldehyde at the C-12 position (5) has allowed for the synthesis of analogues with new carbon-carbon bonds at that position. Previous methods for forming these bonds, such as Grignard and Stille conditions, have met with limited success. We report a palladium catalyzed Liebeskind-Srogl cross-coupling reaction of a thioester and a boronic acid that occurs at neutral pH and ambient temperature to produce ketone analogs at C-12. To the best of our knowledge, this is the first reported usage of the Liebeskind-Srogl reaction to diversify a natural product scaffold. We also describe a one-step protocol for the conversion of 1 to 12-epi-1 (3) through microwave irradiation. Previously, this synthetically challenging process has required multiple steps. Additionally, we report in this study that alkene 9 and aromatic analogues 12, 19, 23, 25, and 26 were discovered to retain affinity and selectivity at kappa opioid receptors (KOP). Finally, we report that the furan-2-yl analog of 1 (31) has similar affinity to 1. Collectively, these findings suggest that different aromatic groups appended directly to the decalin core may be well tolerated by KOP receptors, and may generate further ligands with affinity and activity at KOP receptors. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3100 / 3110
页数:11
相关论文
共 50 条
  • [31] Synthesis of salvinorin A analogues as opioid receptor probes
    Tidgewell, Kevin
    Harding, Wayne W.
    Lozama, Anthony
    Cobb, Howard
    Shah, Kushal
    Kannan, Pavitra
    Dersch, Christina M.
    Parrish, Damon
    Deschamps, Jeffrey R.
    Rothman, Richard B.
    Prisinzano, Thomas E.
    JOURNAL OF NATURAL PRODUCTS, 2006, 69 (06): : 914 - 918
  • [32] Molecular mechanism of biased signaling at the kappa opioid receptor
    El Daibani, Amal
    Paggi, Joseph M. M.
    Kim, Kuglae
    Laloudakis, Yianni D. D.
    Popov, Petr D.
    Bernhard, Sarah M. M.
    Krumm, Brian E. E.
    Olsen, Reid H. J.
    Diberto, Jeffrey
    Carroll, F. Ivy
    Katritch, Vsevolod
    Wuensch, Bernhard
    Dror, Ron O. O.
    Che, Tao
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [33] The kappa opioid receptor: from addiction to depression, and back
    Lalanne, Laurence
    Ayranci, Gulebru
    Kieffer, Brigitte L.
    Lutz, Pierre-Eric
    FRONTIERS IN PSYCHIATRY, 2014, 5
  • [34] Seeking (and Finding) Biased Ligands of the Kappa Opioid Receptor
    Bohn, Laura M.
    Aube, Jeffrey
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (07): : 694 - 700
  • [35] A novel PET radiotracer for imaging the kappa opioid receptor
    Zheng, Ming-Qiang
    Holden, Daniel
    Lin, Shu-Fei
    Mitch, Charlie
    Navarro, Antonio
    Barth, Vanessa
    Quimby, Steve
    Ropchan, Jim
    Carson, Richard E.
    Huang, Yiyun
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 : S18 - S19
  • [36] Kappa opioid receptor tolerance in the guinea pig hippocampus
    Jin, WZ
    Terman, GW
    Chavkin, C
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 281 (01): : 123 - 128
  • [37] Molecular interactions of salvinorin a at the kappa opioid receptor.
    Kane, BE
    McCurdy, CR
    Ferguson, DM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U57 - U57
  • [38] Kappa opioid receptor is expressed in the rat cerebellar cortex
    Luis A. Herráez-Baranda
    José Carretero
    Rogelio González-Sarmiento
    Raquel E. Rodríguez
    Cell and Tissue Research, 2005, 320 : 223 - 228
  • [39] Arylacetamides as peripherally restricted kappa opioid receptor agonists
    Kumar, V
    Marella, MA
    Cortes-Burgos, L
    Chang, AC
    Cassel, JA
    Daubert, JD
    DeHaven, RN
    DeHaven-Hudkins, DL
    Gottshall, SL
    Mansson, E
    Maycock, AL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (22) : 2567 - 2570
  • [40] Kappa Opioid Receptor-Based Treatments for Pain
    Assana, C.
    Feller, C.
    Fogel, M.
    Frelka, A.
    Gottfried, S.
    Jaber, R.
    Keyes, M.
    Koehler, M.
    Kujawa, K.
    Lautz, N.
    Olson, S.
    Pena, J.
    Ries, L.
    Schauer, L.
    Scherrer, C.
    Strandberg, C.
    Strandberg, S.
    Cunningham, Christopher
    FASEB JOURNAL, 2014, 28 (01):